Desoximetasone topical therapy is indicated to treat inflammatory hyperkeratotic dermatosis (thickening of the outer layer of skin with inflammation) and plaque psoriasis. Corticosteroids exert multiple physiologic actions such as cellular signaling, immune modulation, inflammation and protein regulation, and vasoconstriction. The exact mechanism in the treatment of psoriasis is unknown. Desoximetasone is a high to very high potency fluorinated corticosteroid compared with other topical corticosteroids. Desoximetasone, a synthetic corticosteroid, has anti-inflammatory, anti-pruritic, and vasoconstrictive actions. The mechanism of its anti-inflammatory effect is unclear, however, it is suggested that its therapeutic efficacy in treating dermatoses may be related to its vasoconstrictor potency.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Desoximetasone, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.